Ms. M. Teresa Shoemaker served as the President and CEO of commercial-stage specialty pharmaceutical company Medexus Pharma, Inc. (formerly Medac Pharma) from January 2013 to May of 2020. She has extensive experience in senior leadership roles with a broad range of commercial and operational expertise in the life science industry, including her role as National Sales Director and later as Senior Director of U.S. Commercial Operations for Pharmion Corporation, where she was integral in the launch of azacitidine for myelodysplastic syndromes. In 2008, when Celgene Corporation acquired Pharmion, Ms. Shoemaker remained as Executive Director of Strategic Commercial Operations working as part of the executive transition team.

Ms. Shoemaker joined Onconova’s Board of Directors in May of 2020 and brings more than 30 years of extensive commercial and leadership experience to the Company.